Brain metabolism and neurological symptoms in combined malonic and methylmalonic aciduria.

Orphanet J Rare Dis

Department of General Pediatrics and Adolescent Medicine, Laboratory of Clinical Biochemistry and Metabolism, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, Mathildenstrasse 1, 79106, Freiburg, Germany.

Published: January 2020

Combined malonic and methylmalonic aciduria (CMAMMA) is an inborn error of metabolism which has been proposed being a benign condition. However, older patients may present with neurological manifestations such as seizures, memory problems, psychiatric problems and/ or cognitive decline. In fibroblasts from CMAMMA patients we have recently demonstrated a dysregulation of energy metabolism with increased dependency on β-oxidation for energy production. Because of the inability of the brain to rely efficiently on this pathway to retrieve the required energy to a great extent, we hypothesize an alternative disease-causing mechanism that does not only include the accumulation of the metabolites malonic and methylmalonic acids. Here, we suggest a novel hypothesis on the possible pathophysiological mechanism responsible for the development of neurological symptoms in the long-run.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977288PMC
http://dx.doi.org/10.1186/s13023-020-1299-7DOI Listing

Publication Analysis

Top Keywords

malonic methylmalonic
12
neurological symptoms
8
combined malonic
8
methylmalonic aciduria
8
brain metabolism
4
metabolism neurological
4
symptoms combined
4
aciduria combined
4
aciduria cmamma
4
cmamma inborn
4

Similar Publications

Background: Uremia (UR) is caused by increased UR-related toxins in the bloodstream. We explored the mechanism of enterogenous toxin methylmalonic acid (MMA) in calcium-phosphorus metabolic disorder in UR rats via the Wnt/β-catenin pathway.

Methods: The UR rat model was established by 5/6 nephrectomy.

View Article and Find Full Text PDF

Background: An enriched understanding is necessary concerning the association between hypertension and cognitive impairment in older adults, particularly regarding the potential underlying mechanisms at a biological level. This study aimed to explore the mediating role of methylmalonic acid (MMA) in the hypertension-cognition link in the older population.

Methods: A total of 2762 adults (age > = 60 years) from the National Health and Nutrition Examination Survey (NHANES) 2011-2014 participated.

View Article and Find Full Text PDF

Background: In dogs, data on reference intervals (RIs) for cobalamin, markers of metabolism (markersBmet), age and sex effects are limited.

Hypothesis/objectives: Establish RI for serum cobalamin, homocysteine, and methylmalonic acid (sMMA) concentrations, urinary methylmalonic acid-to-creatinine ratio (uMMA:crea), and determine effects of sex and age.

Methods: Prospective study using healthy dogs (1-10 years).

View Article and Find Full Text PDF

Objective: Methylmalonic acidemia (MMAs) is known as a severe, complex, and lethal disorder of methylmalonate and cobalamin. The patients with MMA may have developmental, neurological, and metabolic disorders such as liver disease. Here, we aim to evaluate 6 Iranian patients suspected to MMA disorder.

View Article and Find Full Text PDF

Quantitative analysis of methylmalonic acid in human plasma by LC-MS/MS after derivatization.

J Chromatogr B Analyt Technol Biomed Life Sci

November 2024

School of Medicine, Westlake University, Hangzhou 310024, Zhejiang, China. Electronic address:

Article Synopsis
  • Methylmalonic acid (MMA) serves as a reverse biomarker for vitamin B12, but its low sensitivity and interference from isomers create challenges in testing.
  • Researchers developed a fast method to modify plasma MMA at room temperature, using specific reagents to enhance its detectability for liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • The new technique improved the accuracy of MMA measurements, showing strong linearity and excellent precision, with recovery rates between 97.9% and 100.1%.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!